Department of Cardiology and Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Curr Cardiol Rev. 2022;18(3):e261121198323. doi: 10.2174/1573403X17666211126092110.
In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for therapy. Selecting the ideal device for a particular pulmonary embolism subset remains elusive and poorly defined. Knowledge of the risks, benefits, capabilities, and potential limitations of each device is crucial.
在肺栓塞的设备治疗不断变化的格局中,了解新设备治疗方法不断发展背后的原理非常重要。需要深入了解肺栓塞的风险分层和治疗指征。为特定的肺栓塞亚组选择理想的设备仍然难以捉摸且定义不明确。了解每种设备的风险、益处、功能和潜在限制至关重要。